Certain subtypes—such as MLL-rearranged, hyperdiploid B-ALL, mixed phenotype acute leukemia, and ZNF384-rearranged ALL—exhibit particularly high expression levels. This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.